Latest Breaking News On - Shankar musunuri - Page 9 : comparemela.com

Ocugen to Participate in Fireside Chat at Chardan s 7th Annual Genetic Medicines Conference

Ocugen to Participate in Fireside Chat at Chardan s 7th Annual Genetic Medicines Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDaniil gataulinShankar musunuriSenior biotech research analystHead of communicationsHead of clinical developmentOcugen incExchange commissionChief executive officerHuma qamarClinical developmentMedical affairsAnnual genetic medicines conferenceWestin grand centralLooking statements this

Ocugen, Inc Announces Connie Collingsworth Joins Business Advisory Board

MALVERN, Pa., Sept. 21, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today.

Josephw westphalDennis careyBill gatesPat toomeyConnie collingsworthWarren buffettShankar musunuriHead of corporate communicationsOcugen incMelinda gates foundationCompany business advisory boardExchange commissionLeadership teamChief operating officerBusiness advisory boardMelinda french gates

Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023

MALVERN, Pa., Sept. 20, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today.

New yorkUnited statesShankar musunuriOcugen incIntercontinental barclay hotelHead of communicationsExchange commissionChief executive officerCantor fitzgerald global healthcare conferenceTarsier pharmaPrivate securities litigation reform act

OCUGEN ANNOUNCES POSITIVE CLINICAL STUDY UPDATE FROM THE PHASE 1/2 TRIAL OF OCU400, A MODIFIER GENE THERAPY PRODUCT CANDIDATE, FOR THE TREATMENT OF RETINITIS PIGMENTOSA AND LEBER CONGENITAL AMAUROSIS

MALVERN - Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced a clinical study.

Los angelesUnited statesTarun upadhyayLejla vajzovicDavid boyerShankar musunuriDuke vitreoretinal fellowship programDuke eye centerRetina vitreous associates medical groupKeck school of medicine los angelesHead of researchRetina foundation of theOcugen incDuke university school of medicineRetinitis pigmentosaChief executive officer

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shankar musunuriLejla vajzovicTarun upadhyayDuke university school of medicineOcugen incUniversity of miamiHead of clinical developmentHead of communicationsHead of researchBascom palmer eye instituteExchange commissionRetina foundation of theRetinitis pigmentosaLeber congenitalAnalyst eventChief scientific officer